Johnson & Johnson to Acquire Shockwave Medical for $13.1 Billion

Johnson & Johnson to Acquire V-Wave for Up to $1.7 Billion

October 9, 2024

Healthcare Services

Johnson & Johnson (J&J) entered into a definitive agreement to acquire V-Wave, a privately held heart-failure treatment company, for an upfront payment of $600 million and potential regulatory/commercial milestone payments up to about $1.1 billion (total up to ~$1.7 billion). The acquisition is expected to close before the end of 2024, and will add V-Wave’s Ventura Interatrial Shunt implant technology to the J&J MedTech Cardiovascular portfolio.

Shockwave Medical Acquires Neovasc

January 17, 2023

Medical Devices

Shockwave Medical entered into a definitive agreement to acquire Neovasc, a minimally invasive treatment company focused on refractory angina. Under the plan of arrangement, Neovasc shareholders will receive $27.25 per share in upfront cash plus contingent value right (CVR) payments tied to regulatory milestones.

Boston Scientific Agrees to Acquire Bolt Medical

January 8, 2025

Medical Devices

Boston Scientific Corporation entered into a definitive agreement to acquire Bolt Medical, Inc., developer of an intravascular lithotripsy (IVL) laser-based platform for treating calcified coronary and peripheral artery disease. The deal includes an upfront payment of about $443 million for the 74% stake Boston Scientific does not already own, plus up to $221 million tied to regulatory milestones.

Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022

Medical Devices

Johnson & Johnson completed its acquisition of Abiomed through a tender offer and subsequent merger, for an upfront payment of $380.00 per share in cash (enterprise value ~ $16.6 billion), plus a non-tradeable contingent value right (CVR) up to $35.00 per share based on milestones. Abiomed will operate as a standalone business within Johnson & Johnson’s MedTech segment.

Siemens Healthineers to Acquire Varian Medical Systems

August 2, 2020

Medical Devices

Siemens Healthineers AG has agreed to acquire all shares of Varian Medical Systems, Inc. for USD 177.50 per share, valuing the deal at approximately USD 16.4 billion. The transaction, which aims to create an integrated cancer-care portfolio, is expected to close in H1 2021 subject to Varian shareholder and regulatory approvals.

Boston Scientific to Acquire SoniVie Ltd

March 3, 2025

Medical Devices

Boston Scientific Corporation has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company developing the TIVUS intravascular ultrasound system for renal denervation therapy for hypertension. The deal includes an upfront payment of approximately $360 million for the 90% stake Boston Scientific does not already own, plus up to $180 million contingent on achievement of a regulatory milestone.